Company Sector
Nucleic Acid Drugs
Nucleic Acid Drugs includes companies developing RNA, DNA, antisense, siRNA, mRNA, or related therapeutic approaches. This category is useful for tracking businesses whose core assets rely on sequence-based medicines rather than traditional small molecules or antibodies.
Why watch Nucleic Acid Drugs
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Nucleic Acid Drugs news
The latest feed items from companies currently grouped under Nucleic Acid Drugs.
- 01
- 02
- 03
ALNYAlnylam to Webcast Presentations at Upcoming Investor Conferences
Source: Alnylam Pharmaceuticals, Inc.
- 04
ALNYNew Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutris
Source: Alnylam Pharmaceuticals, Inc.
- 05
ALNYAlnylam Issues 2025 Corporate Responsibility Report
Source: Alnylam Pharmaceuticals, Inc.
- 06
ALNYAlnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
Source: Alnylam Pharmaceuticals, Inc.
- 07
ALNYAlnylam to Host Tenth “RNAi Roundtable” Webcast Series
Source: Alnylam Pharmaceuticals, Inc.
- 08
GSKRoy Jakobs to join GSK Board as Non-Executive Director
Source: GSK plc
- 09
GRNAGreenLight Biosciences 2026
Source: GreenLight Biosciences
- 10
GRNAGreenLight Biosciences 2026
Source: GreenLight Biosciences
- 11
GRNAGreenLight Biosciences 2026
Source: GreenLight Biosciences
- 12
GRNAGreenLight Biosciences 2026
Source: GreenLight Biosciences
- 13
SRPTSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Sarepta Therapeutics
- 14
SRPTSarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
Source: Sarepta Therapeutics
- 15
MDNAMedicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
Source: Medicenna Therapeutics Corp.
- 16
- 17
- 18
- 19
MDNAMedicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
Source: Medicenna Therapeutics Corp.
- 20
GSKGSK enters agreement to acquire Nuvalent, Inc.
Source: GSK plc
Companies in Nucleic Acid Drugs
27 companies tagged with Nucleic Acid Drugs.
Frequently Asked Questions
What does the Nucleic Acid Drugs sector include?
Nucleic Acid Drugs includes companies developing RNA, DNA, antisense, siRNA, mRNA, or related therapeutic approaches. This category is useful for tracking businesses whose core assets rely on sequence-based medicines rather than traditional small molecules or antibodies.
How many companies are currently tagged with Nucleic Acid Drugs?
27 companies are currently grouped under Nucleic Acid Drugs on BioPharmSignal.
Which companies are most visible in the Nucleic Acid Drugs group right now?
ALNY, APDN, ATYR, RNA are among the companies currently shown on this sector page.
How can I watch news for Nucleic Acid Drugs?
Use the Watch button on this page to subscribe to Nucleic Acid Drugs headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Nucleic Acid Drugs?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Nucleic Acid Drugs.